PROPHASE LABS, INC. Common Stock ($0.0005 par value per share) Sales AgreementProPhase Labs, Inc. • December 29th, 2021 • Pharmaceutical preparations • New York
ProPhase Labs, Inc., a corporation formed under the laws of the State of Delaware (the “Company”), confirms its agreement (this “Agreement”) with ThinkEquity LLC (“ThinkEquity” or “Agent”), as follows:
